Drugs / Minocyclin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT05644301 Comparator | Sep 2023 → Sep 2026 overdue | major depressive disorder | University of Antwerp | Recruiting | No outcome recorded |
| Phase 3 | NCT05074147 Background | May 2022 → Nov 2024 | osteomyelitis | Tourcoing Hospital | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Minocyclin | “* Minocyclin : 100mg/8h to 12h” NCT05074147 ↗ |
| Route | Oral | “Oral capsule, 100 mg, twice daily, for 12 weeks” NCT05644301 ↗ |